Metraipolis › archive › dc_ee78dd75494c

Precision oncology: AI's breakthrough in TNBC chemoresistance prediction — Europe PMC PMID:41181480

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41181480
DOI
10.1097/ms9.0000000000003790
License (as archived)
solo-consultazione
Archived
2026-11-10T07:18:33.679Z
SHA-256 of the archived text
5aa940fff6d98a76603da9e529666af91bb0f5567108f7b073908e69287f78f7
Stable URL of this page
https://metraipolis.com/documento/dc_ee78dd75494c

How to cite

Precision oncology: AI's breakthrough in TNBC chemoresistance prediction — Europe PMC PMID:41181480 — Europe PMC (en), https://europepmc.org/article/MED/41181480 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee78dd75494c (Metraipolis archive dc_ee78dd75494c, sha256 5aa940fff6d98a76603da9e529666af91bb0f5567108f7b073908e69287f78f7)
BibTeX
@misc{dcee78dd75494c,
  title = {Precision oncology: AI's breakthrough in TNBC chemoresistance prediction — Europe PMC PMID:41181480},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41181480},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee78dd75494c; sha256 5aa940fff6d98a76603da9e529666af91bb0f5567108f7b073908e69287f78f7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41181480. Agents can read the archived copy with the MCP tool read_document.